TECH (Bio-Techne) Cyclically Adjusted Book per Share: $11.45 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TECH Bio-Techne Corp TECH
88 GF Score
Price $72.14
GF Value $72.79
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Bio-Techne Cyclically Adjusted Book per Share?

Bio-Techne TECH +0.06% 88 Cyclically Adjusted Book per Share is $11.45 as of Mar. 2026. GuruFocus rates TECH with a GF Score™ of 88/100 and a GF Value™ of $72.79 (Fairly Valued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Bio-Techne's adjusted book value per share for the three months ended in Mar. 2026 was $13.323. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $11.45 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Bio-Techne's average Cyclically Adjusted Book Growth Rate was 8.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 9.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 11.80% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 10.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Bio-Techne was 32.30% per year. The lowest was 9.20% per year. And the median was 13.15% per year.

As of today (2026-08-04), Bio-Techne's current stock price is $72.14. Bio-Techne's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $11.45. Bio-Techne's Cyclically Adjusted PB Ratio of today is 6.30.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bio-Techne was 19.03. The lowest was 3.78. And the median was 7.95.


Bio-Techne  (NAS:TECH) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bio-Techne's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=72.14/11.45
=6.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Bio-Techne was 19.03. The lowest was 3.78. And the median was 7.95.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Bio-Techne Cyclically Adjusted Book per Share Related Terms


Bio-Techne Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Bio-Techne's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio-Techne Cyclically Adjusted Book per Share Chart

Bio-Techne Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.08 8.29 9.10 9.98 10.80

Bio-Techne Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.60 10.80 11.00 11.10 11.45

TECH vs CYTK, SMMT, BMRN: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Bio-Techne's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Techne Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Techne's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bio-Techne's Cyclically Adjusted PB Ratio falls into.


TECH
88GF Score
Bio-Techne Corp TECH
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio-Techne Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bio-Techne's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=13.323/330.2130*330.2130
=13.323

Current CPI (Mar. 2026) = 330.2130.

Bio-Techne Quarterly Data

Book Value per Share CPI Adj_Book
201606 5.901 241.018 8.085
201609 6.001 241.428 8.208
201612 5.967 241.432 8.161
201703 6.080 243.801 8.235
201706 6.355 244.955 8.567
201709 6.414 246.819 8.581
201712 6.657 246.524 8.917
201803 7.047 249.554 9.325
201806 7.173 251.989 9.400
201809 7.337 252.439 9.597
201812 7.264 251.233 9.548
201903 7.578 254.202 9.844
201906 7.682 256.143 9.903
201909 7.708 256.759 9.913
201912 8.642 256.974 11.105
202003 8.468 258.115 10.833
202006 8.980 257.797 11.503
202009 9.321 260.280 11.825
202012 9.815 260.474 12.443
202103 9.905 264.877 12.348
202106 10.030 271.696 12.190
202109 10.436 274.310 12.563
202112 10.828 278.802 12.825
202203 10.916 287.504 12.538
202206 10.864 296.311 12.107
202209 11.159 296.808 12.415
202212 11.631 296.797 12.941
202303 12.010 301.836 13.139
202306 12.475 305.109 13.501
202309 12.616 307.789 13.535
202312 12.495 306.746 13.451
202403 12.785 312.332 13.517
202406 13.076 314.175 13.744
202409 13.461 315.301 14.098
202412 13.162 315.605 13.771
202503 12.873 319.799 13.292
202506 12.382 322.561 12.676
202509 12.622 324.800 12.832
202512 12.901 324.054 13.146
202603 13.323 330.213 13.323

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $11.45 mean?
Bio-Techne (TECH) has a Cyclically Adjusted Book per Share of $11.45 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Bio-Techne and its competitors.
Is Bio-Techne's Cyclically Adjusted Book per Share too high?
Bio-Techne's current Cyclically Adjusted Book per Share is $11.45. Overall, Bio-Techne has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bio-Techne's Cyclically Adjusted Book per Share compare to CYTK and SMMT?
Bio-Techne's Cyclically Adjusted Book per Share of $11.45 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Bio-Techne and its competitors. Bio-Techne's current Cyclically Adjusted Book per Share is $11.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Techne stock overvalued right now?
Based on GuruFocus' analysis, Bio-Techne (TECH) is currently considered Fairly Valued. The stock's GF Value™ is $72.79, compared to a current price of $72.14 — trading 0.9% below its estimated fair value. The current Cyclically Adjusted Book per Share is $11.45. Bio-Techne's overall GF Score™ is 88/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Bio-Techne (TECH), the current Cyclically Adjusted Book per Share is $11.45 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bio-Techne (TECH) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Techne stock appears to be undervalued. The current stock price of $72.14 is trading 0.9% below its estimated GF Value™ of $72.79. GuruFocus considers Bio-Techne to be Fairly Valued.

Key valuation signals for TECH:

  • Cyclically Adjusted Book per Share: $11.45
  • GF Value™: $72.79 vs. price of $72.14 (0.9% below fair value)
  • GF Score™: 88/100 with 8 warning signs

No single metric tells the full story. See the TECH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bio-Techne Business Description

Other Exchanges TE1:GermanyT1CH34:Brazil
Address 614 McKinley Place N.E., Minneapolis, MN, USA, 55413
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
88GF Score

Get the complete analysis for TECH

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$72.14
Price
$72.79
GF Value